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Cardiovascular diseases are the leading cause of mortality in industrialized 
countries and their prevalence increases with aging populations. Small arteries 
constitute the main site of peripheral vascular resistance and play a key role 
in the regulation of blood pressure. Vascular tone is exacerbated in hyperten-
sion (HBP) and accompanied by a hypertrophy of the arterial wall. Although 
signaling by extracellular nucleotides is important in vascular homeostasis its 
contribution to vascular pathologies affecting small arteries remains poorly 
understood. We evaluated here the expression pattern of nucleotides signaling 
pathway in resistance arteries vs aorta in mice. Genes of interest including P2 
receptors, ectonucleotidases (CD39, CD73) and hemi channels (connexins, 
pannexins) were investigated by quantitative RT-PCR. Their expression in 
resistance arteries was assessed in Angiotensin II-treated mice, spontaneously 
hypertensive rats (SHR) and, since HBP is related to age, in 24-month old 
mice. Our results showed that several genes are more expressed in aorta 
(P2ry2 and connexin 43) while others are expressed specifically (P2rx1, 
connexin 37) or preferentially (P2ry6) in small arteries. The latest might be 
involved in pathologies affecting the small arteries. With HBP, we observed a 
decreased connexin 37 and 40 expression level in Angiotensin II-treated mice 
and in SHR respectively and both decreased with aging. Interestingly, CD39 
(tone regulator) decreased in the two models of HBP and with aging. Such 
decrease in nucleotidase activity may enhance P2 receptors activation and 
increase vascular contractility/tone. This is especially true considering P2Y6 
(tone promoter) that increased with aging. Further studies may allow us to 
evaluate the contribution of these mediators in the development of small 
arteries defect in aging associated or not with HBP. Signaling by extracellular 
nucleotides may constitute new therapeutic targets in the treatment of HBP.
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Deficiency in nitric oxide decreases the microcirculation reactivity in 
response to acetylcholine but is not always associated with a higher 
blood pressure in mice
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Endothelial dysfunction is associated with cardiovascular diseases and can 
be evaluated in clinical setting for risk stratification in patients. Flow mediated 
dilation (FMD) or local acetylcholine (ACh) administration are used to assess 
endothelial dysfunction in arteries but also in microcirculation (MC) using 
Laser Doppler Flowmetry (LDF). In our study, we aim to investigate the role 
of nitric oxide (NO) in the endothelial response of microcirculation in vivo in 
mice. Two strains of mice (C57BL6 and BALBc mice; 20 weeks old) were 
treated with NO synthase inhibitor (L-NAME) in drinking water (1 g/L) and 
compared with their respective untreated controls. After 3 or 7 days of L-
NAME, mice were anesthetized with isoflurane. Systolic blood pressure (SBP) 
was then measured by plethysmography and skin MC assessed by LDF. Blood 
flow was measured at baseline and in response to ACh administered by ionto-
phoresis or during hyperemic response due to local heating at 44°C. At day 3, 
we observed a slight increase in SBP only in BALBc mice treated with L-
NAME (+13 mmHg), not maintained at day 7. Conversely, at day 7, we 
observed an increase in SBP (+30 mmHg) only in L-NAME-treated C57BL6 
mice. MC flow response to ACh was decreased by 65% and 58% in BALBc 
mice at day 3 and 7, respectively, and by 68% in C57BL6 mice only after 
7 days of L-NAME treatment compared to untreated mice. No difference was 
observed in response to local heating, neither between strains nor after L-
NAME treatment. In conclusion, skin microcirculation reactivity can be rou-
tinely assessed in vivo in mice. Our results show that a part of the transitory 
Ach-induced microcirculation flow increase is NO-mediated. Moreover, this 
decrease in NO bioavailability in microcirculation is not always associated 
with increase in systemic BP. Further studies are now required in order to 
determine if the microcirculation response to ACh could be a marker of coro-
nary endothelial function in animal models as it is in human.
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Role of kinins in diabetic wound healing
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The diabetic foot is associated with pain, decrease in patient’s quality of life, 
considerable costs, and amputation. In this study, we determined the role of KKS, 
via activation of bradykinin receptors (B1R or B2R), in a mouse model of dia-
betic wound healing. Diabetic or nondiabetic mice are wounded with an 8-mm 
punch biopsy and then are treated or not with specific B1R or B2R agonists 
(720nmol/kg.d-1) and/or B2R antagonist (Icatibant, 500μg/kg.d-1). The wound-
healing surface was daily followed up. At 11 days, the scar were analysed by his-
tology (Masson’s trichrome staining) and B1R and B2R expression were assessed 
(RT-qPCR). Effects of the agonists on cells (fibroblasts and keratinocytes) migra-
tion and proliferation were also analysed. In diabetic condition, mRNA of B1R 
and B2R was increased in skin (p<0.01). B1R activation had no effect on wound 
closure in our model. In contrast, B2R activation dramatically delayed wound 
healing in diabetic (p<0.001) or nondiabetic (p<0.01) mice. Histological analysis 
of scar showed significant skin disorganization and epidermis thickening with 
B2R agonist (p<0.05). In vitro, B2R agonist induced an increase of keratinocyte 
proliferation (+46% after 48h, p<0.01) and a stimulation of keratinocyte migration 
(+30% after 24h, p<0.05). These effects was associated with ERK phosphoryla-
tion which occurs downstream of EGFR activation (p<0.05). B2R agonist had no 
effect on fibroblast migration but decreased fibroblast proliferation (–33% after 
48h, p<0.05). Co-treatment with Icatibant abrogated in vivo and in vitro effects 
observed with B2R agonist. Moreover, Icatibant alone hastened wound healing 
and decrease the epidermis thickening induced by diabetes. In conclusion, KKS, 
through the B2R but not the B1R, plays a critical role in proliferation and remod-
elling phases of skin wound healing in mice. While more studies are needed, Ica-
tibant could be used to correct the diabetic wound healing defect.
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Objective: Flow (shear stress)-mediated outward remodeling of resistance 
arteries is involved in collateral growth during postischemic revascularization. 
Besides the NO pathway the involvement of inflammatory factors and reactive 
oxygen species has been suggested in this remodeling although the mechanism 
and the sequence remains unknown. As T cells drive the inflammatory 
response, we investigated their role in flow-mediated remodeling. Mouse mes-
enteric resistance arteries (250μm internal diameter) were submitted in vivo to 
a chronic increase (144±18 to 239±25 μl/min) in blood flow. Arteries were 
collected for in vitro analysis after 1 to 7 days.
Results: After 1 week, remodeling occurred in high flow (HF) arteries 
(diameter increased from 242±21μm to 324±20μm, n=xx per group, P<00.1) 
in control mice. No remodeling occurred in nude mice and in mice treated 
with anti-CD3 antibodies. In control arteries lymphocyte T cells accumulate 
around HF arteries at day 1 (shown using both immunohistology and flow 
cytometry) and they expressed angiotensin II type 2 receptor (AT2R). In iso-
lated T cells AT2R stimulation induced preferentially IL-17 production 
(20±6pg/ml to 50±5pg/ml, n=xx per group, P<00.1). We then tested the occur-
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